Berg Carl L, Gillespie Brenda W, Merion Robert M, Brown Robert S, Abecassis Michael M, Trotter James F, Fisher Robert A, Freise Chris E, Ghobrial R Mark, Shaked Abraham, Fair Jeffrey H, Everhart James E
Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Gastroenterology. 2007 Dec;133(6):1806-13. doi: 10.1053/j.gastro.2007.09.004. Epub 2007 Sep 14.
BACKGROUND & AIMS: More than 2000 adult-to-adult living donor liver transplantations (LDLT) have been performed in the United States, yet the potential benefit to liver transplant candidates of undergoing LDLT compared with waiting for deceased donor liver transplantation (DDLT) is unknown. The aim of this study was to determine whether there is a survival benefit of adult LDLT.
Adults with chronic liver disease who had a potential living donor evaluated from January 1998 to February 2003 at 9 university-based hospitals were analyzed. Starting at the time of a potential donor's evaluation, we compared mortality after LDLT to mortality among those who remained on the waiting list or received DDLT. Median follow-up was 4.4 years. Comparisons were made by hazard ratios (HR) adjusted for LDLT candidate characteristics at the time of donor evaluation.
Among 807 potential living donor recipients, 389 underwent LDLT, 249 underwent DDLT, 99 died without transplantation, and 70 were awaiting transplantation at last follow-up. Receipt of LDLT was associated with an adjusted mortality HR of 0.56 (95% confidence interval [CI]: 0.42-0.74; P < .001) relative to candidates who did not undergo LDLT. As centers gained greater experience (>20 LDLT), LDLT benefit was magnified, with a mortality HR of 0.35 (95% CI: 0.23-0.53; P < .001).
Adult LDLT was associated with lower mortality than the alternative of waiting for DDLT. This reduction in mortality was magnified as centers gained experience with LDLT. This reduction in transplant candidate mortality must be balanced against the risks undertaken by the living donors themselves.
美国已开展了2000多例成人对成人活体肝移植(LDLT),但与等待尸体供肝肝移植(DDLT)相比,LDLT对肝移植受者的潜在益处尚不清楚。本研究的目的是确定成人LDLT是否具有生存获益。
分析了1998年1月至2003年2月在9家大学附属医院接受潜在活体供者评估的慢性肝病成人患者。从潜在供者评估时开始,我们比较了LDLT后的死亡率与仍在等待名单上或接受DDLT者的死亡率。中位随访时间为4.4年。通过根据供者评估时LDLT受者特征调整的风险比(HR)进行比较。
在807名潜在活体供者受者中,389例接受了LDLT,249例接受了DDLT,99例未移植死亡,70例在最后随访时仍在等待移植。与未接受LDLT的受者相比,接受LDLT者的校正死亡率HR为0.56(95%置信区间[CI]:0.42 - 0.74;P <.001)。随着中心经验的增加(>20例LDLT),LDLT的获益更加明显,死亡率HR为0.35(95%CI:0.23 - 0.53;P <.001)。
成人LDLT与低于等待DDLT的死亡率相关。随着中心对LDLT经验的增加,这种死亡率的降低更加明显。这种移植受者死亡率的降低必须与活体供者自身承担的风险相权衡。